返回 Agenda
Session 3 : Advancing a paradigm shift in CGT regulatory perspective
Session Chair(s)
So Ra Park
President
Regenerative Medicine Acceleration Foundation, Korea, Republic of
Eui-Kyung Lee, PHD
Professor,School of Pharmacy
SKKU, Korea, Republic of
Speaker(s)
Maria Vassileva, PHD
DIA, United States
Chief Science and Regulatory Officer
Yasuhiro Kishioka, PHD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Review Director, Office of Cellular and Tissue-based Products
Jianchao Gao, MD
Changping Laboratory, China
Associate Researcher
Kyeongsoon Kim, PHD
Dream CIS, Korea, Republic of
Vice President
Youngil Koh, MD, PHD
Seoul National University Hospital, Korea, Republic of
Hemato Oncology, Center for Hematological Oncology